Skip to main content
Erschienen in: Netherlands Heart Journal 1/2008

01.01.2008 | Original article

Mechanisms involved in symptomatic myocardial bridging

Value of sequential testing for endothelial function, flow reserve measurements and dobutamine stress angiography

verfasst von: A. J. C. Hazenberg, G. A. J. Jessurun, R. A. Tio

Erschienen in: Netherlands Heart Journal | Ausgabe 1/2008

Einloggen, um Zugang zu erhalten

Abstract

Background.In patients with extensive myocardial bridging, evaluation of its clinical significance remains a challenge.
Hypothesis.Sequential invasive testing is feasible and gives more insight into the pathophysiological mechanism of bridging-related angina.
Methods.Twelve patients with chest pain, proven ischaemia and extensive myocardial bridging were assessed. Myocardial bridging was evaluated at rest, during intracoronary acetylcholine infusion, through coronary flow velocity and flow reserve measurements, and during dobutamine stress.
Results.The mean length of the bridging segment was 24.9 mm (QCA; range 8.4-48.0 mm). Acetylcholine infusion caused severe vasospasm in two patients. In these two patients anginal symptoms were related to vasospasm and sequential testing was discontinued. In the remaining ten patients sequential testing was continued. Coronary flow reserve was normal in all patients: 3.3±0.6. In six patients reliable quantitative measurements could be performed during dobutamine stress. The mean systolic diameter of the bridging segment was 1.6±0.4 at baseline and 1.3±0.3 during dobutamine stress (mean of differences 0.38 (95% CI 0.1-0.7)). The difference between the diastolic and systolic diameter in the bridging segment increased from 0.3±0.2 mm at baseline to 1.0±0.5 mm during dobutamine infusion (mean of differences 0.6 (95% CI 0.3 to 0.9)).
Conclusion.Sequential testing for bridging is feasible and may disclose endothelial dysfunction or spasm as an underlying mechanism in a minority of patients. Coronary flow reserve was preserved. Dobutamine stress unmasked further lumen reduction and may give further insight into the clinical significance of myocardial bridging in individual patients. (Neth Heart J 2008;16:10-5.)
Literatur
1.
Zurück zum Zitat Bourassa MG, Butnaru A, Lespérance J, Tardif JC. Symptomatic Myocardial Bridges: overview of Ischemic Mechanisms and Current Diagnostic and Treatment Stategies. J Am Coll Cardiol 2003; 41:351-9. Bourassa MG, Butnaru A, Lespérance J, Tardif JC. Symptomatic Myocardial Bridges: overview of Ischemic Mechanisms and Current Diagnostic and Treatment Stategies. J Am Coll Cardiol 2003; 41:351-9.
2.
Zurück zum Zitat Ge J, Erbel R, Rupprecht HJ, Koch L, Kearney P, Gorge G, et al. Comparison of Intravasular Ultrasound and Angiography in the Assessment of Myocardial Bridging. Circulation 1994;89:1725-32. Ge J, Erbel R, Rupprecht HJ, Koch L, Kearney P, Gorge G, et al. Comparison of Intravasular Ultrasound and Angiography in the Assessment of Myocardial Bridging. Circulation 1994;89:1725-32.
3.
Zurück zum Zitat Angelini P, Trivellato M, Donis J, Leachman RD. Myocardial Bridges: A Review. Prog Cardiovasc Dis 1983;26:75-88. Angelini P, Trivellato M, Donis J, Leachman RD. Myocardial Bridges: A Review. Prog Cardiovasc Dis 1983;26:75-88.
4.
Zurück zum Zitat Ge J, Jeremias A, Rupp M, Abels M, Baumgart D, Liu F, et al. New signs characteristic of myocardial bridging demonstrated by intracoronary ultrasound and Doppler. Eur Heart J 1999;20:1707-16. Ge J, Jeremias A, Rupp M, Abels M, Baumgart D, Liu F, et al. New signs characteristic of myocardial bridging demonstrated by intracoronary ultrasound and Doppler. Eur Heart J 1999;20:1707-16.
5.
Zurück zum Zitat Möhlenkamp S, Hort W, Ge J, Erbel E. Update on Myocardial Bridging. Circulation 2002;106:2616-22. Möhlenkamp S, Hort W, Ge J, Erbel E. Update on Myocardial Bridging. Circulation 2002;106:2616-22.
6.
Zurück zum Zitat Tio RA, Ebels T. Ventricular Septal Rupture Caused by Myocardial Bridging. Ann Thorax Surg 2001;72:1369-70. Tio RA, Ebels T. Ventricular Septal Rupture Caused by Myocardial Bridging. Ann Thorax Surg 2001;72:1369-70.
7.
Zurück zum Zitat Tio RA, Van Gelder IC, Boonstra PW, Crijns HGJM. Myocardial bridging in a survivor of sudden cardiac near-death?: Role of intracoronary Doppler flow measurements and angiography during dobutamine stress in the clinical evaluation. Heart 1997;77:280-2. Tio RA, Van Gelder IC, Boonstra PW, Crijns HGJM. Myocardial bridging in a survivor of sudden cardiac near-death?: Role of intracoronary Doppler flow measurements and angiography during dobutamine stress in the clinical evaluation. Heart 1997;77:280-2.
8.
Zurück zum Zitat Haager PK, Schwarz ER, Vom Dahl J, Klues HG, Reffelmann T, Hanrath P. Long term angiographic and clinical follow up in patients with stent implantation for symptomatic myocardial bridging. Heart 2000;84:403-8. Haager PK, Schwarz ER, Vom Dahl J, Klues HG, Reffelmann T, Hanrath P. Long term angiographic and clinical follow up in patients with stent implantation for symptomatic myocardial bridging. Heart 2000;84:403-8.
9.
Zurück zum Zitat Murase Y, Yamada Y, Hirashiki A, Ichihara S, Kanda H, Watarai M, et al. Genetic risk and gene-environment interaction in coronary artery spasm in Japanese men and women. Eur Heart J 2004;25:970-7. Murase Y, Yamada Y, Hirashiki A, Ichihara S, Kanda H, Watarai M, et al. Genetic risk and gene-environment interaction in coronary artery spasm in Japanese men and women. Eur Heart J 2004;25:970-7.
10.
Zurück zum Zitat Teragawa H, Fukuda Y, Matsuda K, Hirao H, Higashi Y, Yamagata T, et al. Myocardial bridging increases the risk of coronary spasm. Clin Cardiol 2003;26:377-83. Teragawa H, Fukuda Y, Matsuda K, Hirao H, Higashi Y, Yamagata T, et al. Myocardial bridging increases the risk of coronary spasm. Clin Cardiol 2003;26:377-83.
11.
Zurück zum Zitat Hongo Y, Tada H, Ito K, Yasumura Y, Miyatake K, Yamagishi M. Augmentation of vessel squeezing at coronary-myocardial bridge by nitroglycerin: study by quantitative coronary angiography and intravascular ultrasound. Am Heart J 1999;138:345-50. Hongo Y, Tada H, Ito K, Yasumura Y, Miyatake K, Yamagishi M. Augmentation of vessel squeezing at coronary-myocardial bridge by nitroglycerin: study by quantitative coronary angiography and intravascular ultrasound. Am Heart J 1999;138:345-50.
12.
Zurück zum Zitat Klues HG, Schwarz ER, Vom Dahl J. Disturbed Intracoronary Hemodynamics in Myocardial Bridging, Early Normalization by Intracoronary Stent Placement. Circulation 1997;96:2905-13. Klues HG, Schwarz ER, Vom Dahl J. Disturbed Intracoronary Hemodynamics in Myocardial Bridging, Early Normalization by Intracoronary Stent Placement. Circulation 1997;96:2905-13.
13.
Zurück zum Zitat Schwarz ER, Klues HG, Vom Dahl J, Klein I, Krebs W, Hanrath P. Functional, Angiographic and Intracoronary Doppler Flow Characteristics in Symptomatic Patients With Myocardial Bridging: Effect of Short-Term Intravenous Beta-Blocker Medication. J Am Coll Cardiol 1996;27:1637-45. Schwarz ER, Klues HG, Vom Dahl J, Klein I, Krebs W, Hanrath P. Functional, Angiographic and Intracoronary Doppler Flow Characteristics in Symptomatic Patients With Myocardial Bridging: Effect of Short-Term Intravenous Beta-Blocker Medication. J Am Coll Cardiol 1996;27:1637-45.
14.
Zurück zum Zitat Schwarz ER, Klues HG, vom Dahl J, Klein I, Krebs W, Hanrath P. Functional characteristics of myocardial bridging. A combined angiographic and intracoronary Doppler flow study. Eur Heart J 1997;18:434-42. Schwarz ER, Klues HG, vom Dahl J, Klein I, Krebs W, Hanrath P. Functional characteristics of myocardial bridging. A combined angiographic and intracoronary Doppler flow study. Eur Heart J 1997;18:434-42.
15.
Zurück zum Zitat Uren NG, Crake T. Resistive vessel function in coronary artery disease. Heart 1996;76:299-304. Uren NG, Crake T. Resistive vessel function in coronary artery disease. Heart 1996;76:299-304.
16.
Zurück zum Zitat Escaned J, Cortes J, Flores A, Goicolea J, Alfonso F, Hernandez R, et al. Importance of diastolic fractional flow reserve and dobutamine challenge in physiologic assessment of myocardial bridging. J Am Coll Cardiol 2003;42:226-33. Escaned J, Cortes J, Flores A, Goicolea J, Alfonso F, Hernandez R, et al. Importance of diastolic fractional flow reserve and dobutamine challenge in physiologic assessment of myocardial bridging. J Am Coll Cardiol 2003;42:226-33.
17.
Zurück zum Zitat Ng E, Jilaihawi H, Gershlick AH. Symptomatic myocardial bridging-a niche indication for drug-eluting stents? Int J Cardiol 2005;99:463-4. Ng E, Jilaihawi H, Gershlick AH. Symptomatic myocardial bridging-a niche indication for drug-eluting stents? Int J Cardiol 2005;99:463-4.
Metadaten
Titel
Mechanisms involved in symptomatic myocardial bridging
Value of sequential testing for endothelial function, flow reserve measurements and dobutamine stress angiography
verfasst von
A. J. C. Hazenberg
G. A. J. Jessurun
R. A. Tio
Publikationsdatum
01.01.2008
Verlag
Bohn Stafleu van Loghum
Erschienen in
Netherlands Heart Journal / Ausgabe 1/2008
Print ISSN: 1568-5888
Elektronische ISSN: 1876-6250
DOI
https://doi.org/10.1007/BF03086110

Weitere Artikel der Ausgabe 1/2008

Netherlands Heart Journal 1/2008 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.